SightfileU.S. market data from official filings

DR REDDYS LABS LTD (RDY)

Name: DR REDDYS LABS LTD (RDY) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001135951 · EDGAR filings · Updated 2026-07-23

DR REDDYS LABS LTD (RDY) has reported institutional ownership of 14.4%, with 246 institutional managers holding positions valued at $1.67B per the latest 13F reporting period.

Institutional ownership

14.4%

Institutional managers

246

Reported 13F value

$1.67B

Filings this week (6)

2026-07-23 — Foreign issuer report (6-K) filed
2026-07-23 — Foreign issuer report (6-K) filed
2026-07-23 — Foreign issuer report (6-K) filed
2026-07-23 — Foreign issuer report (6-K) filed
2026-07-23 — Foreign issuer report (6-K) filed
2026-07-22 — Foreign issuer report (6-K) filed

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, DR REDDYS LABS LTD has 246 institutional holders and institutional ownership of 14.4%.

Insider activity

Insiders reported 0 transactions (0 buys, 0 sells) across 2 reporting insiders, with a net reported value of $0.

Related companies

INNOVIVA INC (INVA) · LEGEND BIOTECH CORP (LEGN) · UFP TECHNOLOGIES INC (UFPT) · PHARVARIS N V (PHVS) · AXOGEN INC (AXGN) · NATIONAL HEALTHCARE CORP (NHC)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-23.